annb0t
Top 20
Bionomics (ASX:BNO) First Half 2023 Results
Key Financial Results
Net loss: AU$16.2m (loss widened by 24% from 1H 2022). AU$0.012 loss per share. earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
Bionomics Earnings Insights
Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Biotechs industry in Australia.
Performance of the Australian Biotechs industry....
>>> Read more: Bionomics First Half 2023 Earnings: AU$0.012 loss per share (vs AU$0.013 loss in 1H 2022)
Key Financial Results
Net loss: AU$16.2m (loss widened by 24% from 1H 2022). AU$0.012 loss per share. earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
Bionomics Earnings Insights
Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Biotechs industry in Australia.
Performance of the Australian Biotechs industry....
>>> Read more: Bionomics First Half 2023 Earnings: AU$0.012 loss per share (vs AU$0.013 loss in 1H 2022)
